Slingshot members are tracking this event:

New Bristol-Myers Squibb Research on Opdivo (nivolumab) Monotherapy and in Combination With Yervoy (ipilimumab) to be presented at SMR 2016 Congress Reinforces Immuno-Oncology Leadership and Scientific Expertise in Melanoma

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
BMY Community voting in process
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 09, 2016
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Opdivo, Nivolumab, Yervoy, Ipilimumab